booksshare.net -> -> -> .. -> " " -> 92

- ..

.., .. .: , 2008. 224 c.
ISBN 978-5-9704-0578-9
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 86 87 88 89 90 91 < 92 > 93 94 95 96 97 98 .. 345 >>

9a-fluoro-16a-methyl-l 1/3,17,21-trihydroxypregna-l,4-diene“3,20-dione-21-dihydrogenphosphate
H0-CH2
0
,. i \ л Ц _, {Pyndin]
H [_ у-СНэ + 0 N-P-Ct -
Nv
U
Dexamethason
(s. S. 278)
Oimorpholino-
phosphoroxychlorid
282 D Dexamethasonphosphat - Dexamethasonpivalat
Dexamethasonphosphat
iDi-Na-Saiz)
DBP 1 134075 (Merck AG, Anm. 26.11.1959). weiteres Verfahren: USP 2 939 873 (Merck & Co.; ert. 7.6.1960; Anm. 26.1.1959; Prior. 20.11.1957). K. Jrmscher, Chem. Ind. 1961,1035.
D: Decadron® Phosphat (Sharp & Dohme) Dexamed® (Medice)
Spersadex® (Baeschlin)
F: Cebedex® (Chauvin-Blache)
Cebedexacoi® (Chauvin-BIache)-Komb. Cebefrasone® (Chauvin-Blache)-Komb. Chibro-Cardon® (Chibret)-Komb. Corticetine® (Chauvin-BIache)-Komb. Decalibour® (Merck Sharp & Dohme)-Komb. Dexaderme® (Chauvin-Blache)-Komb. Soludecadron® (Merck Sharp & Dohme)
GB: Decadron® (Merck Sharp & Dohme)
I: Decadron Fosfato® (Merck Sharp & Dohme) DesaJark® (Farm. Mil.)
Eta-Cortilen® (Sifi)
Dexamethasonpivalat 1926-94-9
(Dexametasontrimethylacetat)
Megacort® (Lancet)
Soldesam® (Farm. Mil.)
J: Decadron® (Banyu)
USA: Decadron Phosphate® (Merck Sharp & Dohme) Decadron Respihaler® (Merck Sharp & Dohme) Decaject® (Mayrand)
Dexacen® (Central Pharma)
Dexone® (Mallard)
Hexadrol® Phosphate (Tutag)
Maxidex® (Alcon)
Neo-Decadron® Phosphate (Merck Sharp «Sc Dohme)-Komb.
Neo Methalone® (Allergan)-Komb. Prodecaderon Respihaler® (Merck Sharp «Sc Dohme)-Komb.
Glucocorticoid
9a-fIuoro-l6a- methyl-11Д 17,2 l-trihydroxypregna-l,4-diene-3,20-dione-21-trimethylacetate
HO~CH\^o
^^Х>‘‘СНз - (HsCbC-COCI -^1
Dexamethason Pivalinsaure-
(s.S.276) ch(orid
USP 3 033 881 (Ciba; ert. 8.5.1962; CH-Pnor. 4.7.1958). CH-P 398 585 (Ciba; Anm. 1956) Weitere Verfahren: Span-P 320497 (Lab. M. Cuatrecasas; Anm. 30.11.1965). DOS 2 317 954 (Jelen. Zakiady Farm. Polfa; Anm. 10.4.1973; PL-Prior. 21.4.1972).
D: Mi)licorten®-Vioform® (Ciba)
Otriven®-Millicorten® (Ciba)-Komb.
Dexamethason-fert-butylacetat - Dexamethasonvalerat - Dexbrompheniramin D 283
Dexamethason-ferf- 24668-75-5 Glucocorticoid
butylacetat
9tf-Huoro-16a-methyl-l 1(3,17,21-trihydroxypregna-l,4-diene-3,20-dione-21-terr-butylacetate
HO-CH2 Nc-° н0ч^\Ы;*0Н "СИз + llH3C)3C-CH2-C0],0 H [ Pyrrdin ] ШзС)зС-СН2“С0-0-СН2 чс'° H0V^xM;-0H Xм X. / СНз
Dexamethason ferf-Butylessigsaure- Dexamethason-ferNbutyiacetat
(s. s. 278) anhydrid
DOS 2 317 954 (Jelen. Zaklady Farm. Polfa; Anm. 10.4.1973; PL-Prior. 21.4.1972). Inhalationslosung: USP 3 282 781 (Merck & Co. ert. 1Л1.1966; Prior. 25.11.1960).
D: Dissiden® (Allergopharma)-Komb. Nasicortin® (Merck)-Komb. USA: Decadron T.B.A.® (Merck Sharp & Dohme)
Dexamethasonvalerat 33755-46-3 Glucocorticoid
9a-fluorol6tt-methyI-21/3,17,2 Mrihydroxypregna-l,4-diene-3,20*-dione-21-pentanaate
0 CiHg Л^к/''СНз + [C00H)2 ->- * HO-CH2 9 i 0 “ CO - CiHg ^—СИз 1
17,21-O-ButyM-methoxy- Qxalsaure Dexamethasonvalerat
met hy lerdtoxy) - 3,20 - dioxo -9-fluor-И/5-hydroxy-16 a-methyl -1,4-pregnadien (vgl. Betamethasonvalerat, S. 101)
DOS 2111 114 (Inst. Luso Farmaco; Anm. 9.3.1971; I-Prior. 14.3.1970). Weitere Verfahren: DOS 2 055 221 (Lab. Chim. Farm. Blasina; Anm. 10.11.1970).
I: Dermadex® (Zambeletti) Desaval® (Lusofarmaco)
Dexbrompheniramin 132-21-8 Antihistaminicum
2391-03-9 Mai eat
(+)-2-[p-bromo-a-(dimethylaminoethyl)benzyl]-pyridine
284 D Dexbrompheniramin - Dexchlorpheniramin - Dexpanthenol
, . . _ . o-PhenylQeinsteinsaure [I )-Bromphemramm -■-
-^^-CH-CHz-CHz-N7
СНз
6
(+ )-Dexbrompheniramm
USP 3 030 371 (L. A, Walter; ert. 17.4.1962; Anm. 1958).
USP 3 061517 (Schering Corp.; ert. 30.10.1962; Prior. 16.2.1962).
USA: Disomer® Chronotab® (Schering) Drixoral® (Schering)-Komb.
Disophrol® (Schering)-Komb.
Dexchlorpheniramin 25523-97-1 Antlhistaminicum
2438-32-6 Maleat
(+)-2-[p-chloro-a-(2-dimethylaminoethyl)benzylJ-pyridine
0 - Phenylbernsteinsaure
:i-C3_ch_ch2_ “6"
CH3
CH2—N
''Нз
Dexchlorpheniramin
GB-P 834 984 (Scherico; Anm. 4.7.1958; USA-Prior. 4.3.1958).
USP 3 030 371 (L. H. Waiter; ert. 17.4.1962; Anm. 4.3.1958).
USP 3 061 517 (Schering Corp.; ert. 30.10.1962; Prior. 16.2.1962).
D: Polaronil® (Byk-Essex) F: Ceiestamine® (Cetrane) Polaramine® (Cetrane)
I: Destral® (Tiber)
Polaramin® (Essex)
J: Polaramine® (Schering-Shionogi) USA: Polaramine® (Schering)
Dexpanthenol
(Pantothenylalkohol; Panthenol)
81-13-0
Wuchsstoff;
Wundbehandlungsmittel
D-( + )-2,4-dihydroxy-yV-(3-hydroxypropyl)-3,3-dimethylbutyramide
НзС он *■£. •
D-M-2-Hydro-xy-3,3-dimethyl-i-butanolid (D-(-)-Panto-lacton)
HzN-CH2-CH2-CH2-OH
3-Aminopropanol
j H3c OH j
[нзс-с-сн-со-мн-снг-снг-снг-он I
CHz-OH
Dexpanthenol
USP 2413 077 (Roche; ert. 1946; CH-Prior. 1942). Anwendung als Aerosol:
DAS 2531 260 (Desitin-Werke; Anm. 12.7.1975).
Dexpanthenol - Dextromoramid - Dextropropoxyphen D 285
<< 1 .. 86 87 88 89 90 91 < 92 > 93 94 95 96 97 98 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed